years of age.5 However, feasibility and utility of this method of treatment has not been studied in children of a younger age group where oral drug administration may be a problem because of the inability of the sick child to eat or drink. Aminophylline infusion, which was the mainstay of treatment of children with acute severe asthma before the advent of nebulised 1B sympathomimetics, is being considered as the second line drug because of its potential toxicity and need for serum drug concentration monitoring. ' However, this drug is still used in India on a wide scale because of its low cost and the non-availability of nebulisers in many hospitals. We designed a treatment protocol comprising continuous nebulised salbutamol and oral once a day prednisolone and compared it with a conventional and still widely practised protocol comprising aminophylline infusion and intravenous hydrocortisone in treatment of children with status asthmaticus.
Patients and methods
This study was conducted during the months of April to July 1991. Patients with bronchial asthma diagnosed by a doctor who presented to the paediatric emergency department in acute severe asthma that was unresponsive to two subcutaneous injections of terbutaline 0015 mg/kg given at half hourly intervals were included in the study. Children below 3 years of age were excluded. The parents had the purpose of the study explained and only those children where informed parental consent was available were allocated to the study.
Patients who met the inclusion criteria were divided into the study and the 'control' (or conventional) treatment groups alternately as they presented to the emergency room.
The study was not blinded and the clinical progress of the patients was monitored objectively. Clinical severity in both the groups was assessed at admission using a clinical scale and transcutaneous oxygen saturation (Sao2) The mainstay of treatment in this group was continuous aminophylline infusion 0 9 mg/kg/ hour and intravenous hydrocortisone 10 mg/kg to start with followed by 5 mg/kg every six hours. Intermittent nebulised salbutamol was given after six hours of treatment if the response was considered unsatisfactory.
Maintenance drugs in both the groups were started once a patient achieved a PEFR value of 75% of expected according to locally available standards.6
The patients in this group were given an oral dose of prednisolone 1.5 mg/kg to start with followed by the same dose every 24 hours that was given in the morning. If the patients were unable to ingest the drug at admission due to sickness they were administered the equivalent amount of hydrocortisone intravenously initially and this was followed by oral prednisolone on a once a day basis. Continuous nebulised salbutamol at a concentration of 0 5% and at a dose of 0-15 mg/kg/hour (each aliquot of solution was put in the nebulisation chamber after dilution with equal amount of normal saline) was given by MEDAP nebuliser driven by an air com- A better response with protocol A further strengthens the belief that continuous nebulised ,B sympathomimetics plus oral steroids and oxygen are sufficient for management of acute severe asthma. The risk of serious side effects that has limited the use of continuous P sympathomimetic in adults were not experienced by children probably because of their better cardiac reserve. Aminophylline is associated with much higher rates of toxicity and case fatality and needs serum drug concentration monitoring because of a low therapeutic index. 13 The ability of aminophylline to improve diaphragmatic contractibility is also not beyond doubt.14 Moreover, aminophylline has no significant effect on ventilatory endurance at therapeutic concentrations. 15 Its use, therefore, may only be recommended in cases where no improvement occurs after the first six hours of treatment with continuous nebulised salbutamol and oral steroids.
It was possible to reduce the period of severity of status asthmaticus in the study group leading to shorter period of hospitalisation.
This study does not compare continuous nebulised salbutamol and oral prednisolone with the standard treatment protocol in the UK for severe asthma, which consists of nebulised salbutamol, aminophylline, and hydrocortisone. Our protocol can be tried because it promises to provide a safe and convenient way of treating status asthmaticus as use of intravenous drugs is minimised. Previous studies on continuous nebulisation were different from our study as they used continuous nebulised terbutaline in patients who had failed to respond to intravenous aminophylline and intermittent nebulisation and would have required ventilation.3 4 Also the previous studies did not include any controls as they were not prospectively planned. The protocol tried by us has been found useful in the initial management of status asthmaticus. Medicinal poisoning meant poisoning with analgesic or psychotropic drugs in 44% of cases. In the early years of the study aspirin was the preponderant analgesic but later paracetamol was more common. Berries or mushrooms were eaten by nearly 98% of the children poisoned by plants. Corrosive substances were responsible in 22% of non-medicinal, non-plant poisonings. As expected, there were more boys than girls. Children less than 2 years (the crawlers) were more likely to take non-medicinal poisons than those over 2 (the climbers). Admission rates for medicinal poisoning fell by an average of 5-8% per annum during the years of the study. For nonmedicinal, non-plant poisoning the fall was 6 9% per anum, and for plant poisoning it was 12-8% per annum. The authors point out that admissions for poisoning by drugs now packaged in child resistant containers fell less than those for poisons not so packaged. They give no data about factors affecting rates of hospital admission or about local factors concerning public education or the availability of poisons. There could, for instance, have been a blight affecting berries and mushrooms; perhaps unlikely, but possible.
Their main messages, however, are independent of the quality of their data. Poisoning in young children involves more than drugs and educational efforts must take into account household and plant materials. As readmission for repeated poisoning seems to be uncommon, educational programmes must be directed at the whole population and not just at the families of children who have been poisoned. 
